Tumor and Stem Cell Biology Cancer Research Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells
暂无分享,去创建一个
G. Castellano | M. Pisanu | E. Venturini | Z. Bhujwalla | S. Canevari | F. Podo | E. Iorio | M. Di Vito | D. Mezzanzanica | M. Bagnoli | K. Glunde | A. Ricci | M. D. Vito
[1] C. Cordon-Cardo,et al. A critical role for choline kinase-α in the aggressiveness of bladder carcinomas , 2009, Oncogene.
[2] M. Pomper,et al. Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells. , 2009, Neoplasia.
[3] B. Krishnamachary,et al. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft. , 2009, Cancer research.
[4] T. Aoki,et al. Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells. , 2009, Archives of biochemistry and biophysics.
[5] R. Gillies,et al. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway , 2009, NMR in biomedicine.
[6] S. Canevari,et al. Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells. , 2008, Cancer research.
[7] M. Burg,et al. GDPD5 is a glycerophosphocholine phosphodiesterase that osmotically regulates the osmoprotective organic osmolyte GPC , 2008, Proceedings of the National Academy of Sciences.
[8] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[9] V. Raman,et al. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells. , 2007, Cancer research.
[10] Weiwei Wang,et al. Phosphatidylcholine‐specific phospholipase C and ROS were involved in chicken blastodisc differentiation to vascular endothelial cells , 2007, Journal of cellular biochemistry.
[11] Marcin Skrzypski,et al. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. , 2007, The Lancet. Oncology.
[12] S. Canevari,et al. Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer : Molecular Bases for Noninvasive Imaging Approaches , 2007 .
[13] H. Degani,et al. Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies , 2007, International journal of cancer.
[14] N. Serkova,et al. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. , 2006, Pharmacogenomics.
[15] Aditya Bansal,et al. Choline Transporter as a Novel Target for Molecular Imaging of Cancer , 2006, Molecular imaging.
[16] Ellen Ackerstaff,et al. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. , 2006, Molecular pharmaceutics.
[17] G. N. Sastry,et al. Choline kinase: an important target for cancer. , 2006, Current medicinal chemistry.
[18] Christopher Nimsky,et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. , 2006, Radiology.
[19] B. Jönsson,et al. Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. , 2006, The Biochemical journal.
[20] J. Griffiths,et al. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. , 2006, Cancer research.
[21] V. Raman,et al. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. , 2005, Cancer research.
[22] S. Canevari,et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. , 2005, Cancer research.
[23] R. Gillies,et al. In vivo magnetic resonance spectroscopy in cancer. , 2005, Annual review of biomedical engineering.
[24] F. Podo,et al. Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. , 2004, Experimental cell research.
[25] Y. Yonekura,et al. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. , 2004, Nuclear medicine and biology.
[26] Z. Bhujwalla,et al. Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline. , 2004, Molecular imaging.
[27] D. Megías,et al. Choline Kinase Activation Is a Critical Requirement for the Proliferation of Primary Human Mammary Epithelial Cells and Breast Tumor Progression , 2004, Cancer Research.
[28] Chien-Kuo Wang,et al. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. , 2004, Radiology.
[29] S. Canevari,et al. CD95-Mediated Apoptosis Is Impaired at Receptor Level by Cellular FLICE-Inhibitory Protein (Long Form) in Wild-Type p53 Human Ovarian Carcinoma , 2004, Clinical Cancer Research.
[30] Z. Bhujwalla,et al. Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer , 2004, Cancer Research.
[31] C. Aoyama,et al. Structure and function of choline kinase isoforms in mammalian cells. , 2004, Progress in lipid research.
[32] Z. Bhujwalla,et al. Choline phospholipid metabolism: A target in cancer cells? , 2003, Journal of cellular biochemistry.
[33] A. Morris,et al. Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells Published, JLR Papers in Press, July 1, 2003. DOI 10.1194/jlr.M300188-JLR200 , 2003, Journal of Lipid Research.
[34] E. Yoshikawa,et al. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] J. Horwitz,et al. Measurements of phospholipases A2, C, and D (PLA2, PLC, and PLD). In vitro microassays, analysis of enzyme isoforms, and intact-cell assays. , 2003, Methods in molecular biology.
[36] Jose M. Silva,et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy , 2002, Oncogene.
[37] H. Degani,et al. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. , 2002, Cancer research.
[38] J. Nelson,et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. , 2001, Cancer research.
[39] G. Mills,et al. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[40] F. Podo. Tumour phospholipid metabolism , 1999, NMR in biomedicine.
[41] Z. Bhujwalla,et al. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.
[42] M. Frohman,et al. Measurement of phospholipase D activity. , 1997, Analytical biochemistry.
[43] V. Brusic,et al. Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA‐restricted cytotoxic T cells , 1997, International journal of cancer.
[44] P. Hergenrother,et al. Determination of the kinetic parameters for phospholipase C (Bacillus cereus) on different phospholipid substrates using a chromogenic assay based on the quantitation of inorganic phosphate. , 1997, Analytical biochemistry.
[45] W. V. van Blitterswijk,et al. Involvement of Phosphatidylcholine-specific Phospholipase C in Platelet-derived Growth Factor-induced Activation of the Mitogen-activated Protein Kinase Pathway in Rat-1 Fibroblasts* , 1997, The Journal of Biological Chemistry.
[46] F. Podo,et al. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. , 1996, Anticancer research.
[47] R. Testi,et al. Multiple pathways originate at the Fas/APO‐1 (CD95) receptor: sequential involvement of phosphatidylcholine‐specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. , 1995, The EMBO journal.
[48] W. Negendank,et al. Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.
[49] V. Balzani,et al. Supramolecular Photochemistry and Photophysics. Adducts of Metal Complexes with the Natural Ionophore Lasalocid A Anion , 1992 .
[50] F. Podo,et al. Activation of glycerophosphocholine phosphodiesterase in friend leukemia cells upon in-vitro induced erythroid differentiation. 31P and 1H NMR studies , 1992 .
[51] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.